Detalhe da pesquisa
1.
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
Cell
; 184(9): 2316-2331.e15, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33773105
2.
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress.
Cell
; 184(17): 4430-4446.e22, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416147
3.
Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins.
Immunity
; 54(4): 781-796.e4, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33675683
4.
Somatic Hypermutation and Framework Mutations of Variable Region Contribute to Anti-Zika Virus-Specific Monoclonal Antibody Binding and Function.
J Virol
; 96(11): e0007122, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575481
5.
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries.
MAbs
; 14(1): 2002236, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967699
6.
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
bioRxiv
; 2021 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33501445
7.
Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.
Cell Host Microbe
; 27(6): 976-991.e11, 2020 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320678
8.
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection.
EBioMedicine
; 54: 102733, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315970
9.
Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics.
Nat Biomed Eng
; 4(11): 1030-1043, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747832